Assessing the Economic Impact of Adverse Drug Effects

By Rodríguez-Monguió R.  

PharmacoEconomics, Vol. 21, Iss. 9, 2003-01 ,pp. : 623-650

Adis International

Access to resources Recommend Favorite

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

By Kostapanos Michael S.   Milionis Haralampos J.   Elisaf Moses S.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 11-28

Adis International

Access to resources Recommend Favorite

Adverse drug effects in elderly people – a disparity between clinical examination and adverse effects self-reported by the patient

By Lampela Pasi   Hartikainen Sirpa   Sulkava Raimo   Huupponen Risto  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 5, 2007-05 ,pp. : 509-515

Springer Publishing Company

Access to resources Recommend Favorite

Psychiatric Drug Discovery and Development

By Maubach Karen  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1571-1575

Informa Healthcare

Access to resources Recommend Favorite

Assessing the Feasibility of Using an Adverse Drug Reaction Preventability Scale in Clinical Practice: A Study in a French Emergency Department

By Olivier P.  

Drug Safety, Vol. 25, Iss. 14, 2002-01 ,pp. : 1035-1044

Adis International

Access to resources Recommend Favorite